As of Q4'25, RXRX reported an EPS of -0.21 USD, marking a significant improvement compared to previous quarters. The year-over-year EPS growth for this period reached 63.16%, indicating a strong positive turnaround in earnings performance. Over the period from Q1'23 to Q4'25, RXRX's EPS exhibited a generally negative trend, with values fluctuating between -0.57 USD and -0.21 USD. While the company experienced deeper losses in late 2024, particularly in Q4'24 with an EPS of -0.57 USD, the subsequent quarters showed a steady recovery, culminating in the best EPS result of the series in Q4'25. The YoY growth line highlights periods of both contraction and recovery, with notable positive spikes in Q3'24 and Q4'25, suggesting improving operational efficiency or revenue growth towards the end of the observed timeframe.